Some Medicare plans may cover Basaglar, but it varies by plan. Learn which plans cover Basaglar, how to find coverage, and what you can expect to pay.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), fast-acting lispro ... The company has two approved medical ...

Heather Long is a Post Opinions columnist. She was formerly U.S. economics correspondent from 2017 to 2021 and played a large role in identifying and covering the K-shaped recovery from the ...

After many delays, $2B Iron Range project revives quest to create first new taconite mine since 1970s Mesabi Metallics lost critical state mineral leases last year, leaving an even bigger question ...

If you have COVID-19, you may be wondering how long your illness will last. Your infection time will vary, but generally, a mild case of COVID usually resolves in one to two weeks. It may take up ...

These single use insulin pens collectively build up to create a phenomenal amount of waste. A lot of people, including clinicians, don't realise that reusable pens are safe and easy to use, and often ...

don't realise reusable pens are both safe and easy to use, and often work out cheaper for the NHS in the long run. "My mission is to ensure people who need to use insulin, and healthcare workers ...

Novo Nordisk is investing further in obesity and metabolic disease, signing a deal to use Ascendis Pharma’s delivery technology to advance a long-acting GLP-1 drug as well as develop products in ...

If your pain is more severe, you may be given something stronger, such as oxycodone. Your healthcare provider may try both short-acting and long-acting forms to see what works best for your pain. He ...